• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications

$3,000.00 – $6,000.00

Clear
SKU: KLI1074786 Categories: Over-the-Counter (OTC) Drugs, Pharmaceuticals Market Research Pages: 312
  • Description
  • Table of Contents
  • Latest reports

Description

This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace.

In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of dosage forms, brand names, and distribution/retail channels. Media spending by brand and various innovative promotional activities and marketing approaches are reviewed in detail, and extensive market share information is provided at both the marketer and branded product levels. New product launches in traditional and alternative therapy spheres are reviewed, and the impact of product messaging, packaging, and various other retail trends are discussed.

For the purposes of this study, the market for OTC CCSA products are segmented in the following main categories and subcategories.

  • Cold/Allergy/Sinus Medication
    • Antihistamines
    • Non-sedating antihistamine
    • Decongestants
  • Cough Medication
    • Antitussives
    • Expectorants
  • Combination Products
    • Cold/allergy/sinus medication
    • Cough medication
  • Other
    • Cold/allergy/sinus medication
    • Cough medication
  • Nasal products
    • Nasal aspirators
    • Nasal spray/drops/inhaler
    • Nasal strips
    • Mast cell stabilizers
  • Chest rubs

In addition, 11 top competitors are profiled in depth including product lines, product performance, product mix, and strategic approach.

Table of Contents

Chapter One: Executive Summary

  • Scope
  • Categories
  • Methodology
  • The Market
  • Major Marketers
  • Major Brands
  • Market Structure
  • Market Projections
  • Marketers
    • Cold Allergy Sinus
    • Cough Medication
    • Combination CCSA Medication
    • Others CCSA Medication
    • Nasal Products
    • Chest Rubs
    • Consumers
    • Cold/Allergy/Sinus
    • Sore Throat
    • Cough Syrup
    • Children
  • Key Issues and Trends
    • Curbs on Methamphetamine
    • Seasonal Market
    • Consumer Trends
    • Flavor Trends
    • Trends in Dosing forms
  • Growth Factors
    • Rx to OTC Switch
    • Generics/Private Labels
    • Global Branding
    • Product Extensions
    • Alternative Remedies
    • Advertising Expenditure
    • Retail

Chapter Two: The Market

  • Introduction
  • Epidemiology of Conditions
  • Product Segmentation

 

The Market

  • Overview
  • Market Size
  • Smaller Players Maintain Growth

 

Key Market Players

  • Top Marketers
  • No Dominant Brand
  • Market Structure
  • Combinations Take the Lead
  • Market Projections
  • Overall Market to Reach $4.93 Billion by 2009
  • Regulatory Environment
  • FDA
  • Brand and Generic Names
  • The Cost Factor
  • Approval Process
  • OTC and Prescription Drugs
  • Rx-to-OTC Switch
  • Dual Regulatory Status

 

OTC Switching and the Marketplace

  • Pharmaceutical Company Perspecitve
  • Managed Care Perspective
  • The Consumer’s Perspective

 

Labeling Issues

Advertising and Promotional Guidelines

  • The FDA- Promotional Guidelines
  • Basic Regulatory Standards
  • Substantiation of Claims
  • Comparative Advertising
  • Contests and Sweepstakes
  • Prescription Drug Advertising

Chapter Three: The Marketers

  • Cold Allergy Sinus Category
    • Overview
    • Sales Trends
    • Market Share
    • Claritin Leads the Way
    • Antihistamine
    • Non-Sedating Antihistamine
    • Pre Claritin Era
    • Claritin Drives Growth
    • Future Trends
    • Decongestants
    • Future Trends
  • Cough Medication
    • Overview
    • Sales Trend
    • Expectorants
    • Antitussives
    • Sales Trends
  • Combinations
    • Sales Trends
    • The Pseudoephedrine Effect
    • Cough Combinations
    • Cold Allergy Sinus Combinations
  • Others
    • Others—Cough
    • Other—Cold/Allergy/Sinus
  • Nasal Products
    • Overview
    • Nasal Sprays/Inhalers/Drops
    • Nasal Aspirators
    • Mast Cell Stabilizers
    • Nasal Strips
  • Chest Rubs

Chapter Four: The Consumer

  • Note on Simmons Survey Data and Figures
  • OTC Usage Overview
  • Demographics Favoring OTC over Prescription
  • Cold Allergy Sinus
    • Cold Medication More Popular
    • Allergy Sinus Sufferers Heavy Users
    • Younger Generation Leans toward Daytime Medicines
    • Tylenol Allergy/Sinus More Popular with Older Generation
    • Sudafed Nasal Decongestant Preferred by Middle-Aged Population
  • Sore Throat
    • Lozenges are Most Popular Type of Dosage
    • Regular Sore Drops Ride High
    • Vicks More Popular in Younger Generation; Cepacol Preferred by Older Generation
  • Cough Syrup
    • Younger Generation Skewed Toward Cough Suppressants
    • Older Generation More Frequent Users
  • Children/Pediatric Products
    • Largest Market Group—Children
    • Liquids Highly Popular
    • Children Vicks Nyquil—A Young Parent’s Choice
    • Pediacare Popular with Young Mothers

Chapter Five: Issues and Trends

  • The ‘Meth’ Effect
  • Growing Healthcare Costs
  • Payor Pressures
    • The Insurer Push
    • Revenue Protection
  • Reimportation of Drugs
  • Seasonal Variation
  • Demographics
    • Children—The Largest Market
    • Birth Rate Trends
  • Growing Share of Uninsured Population
  • Technological Society
  • Consumer Acceptance of Self-Medication
  • Key Growth Factors
    • Rx to OTC Switch
    • The Growth of Generics/Private Labels
    • Third Class of Drugs
    • Importance of Establishing a Global Brand
    • Analgesic Combinations—The Entry Strategy
    • Brand Extensions
    • Extended-Release Single Ingredient Cough Products
    • Day-Night Products
  • Unconventional Remedies
    • Vitamin C-Based Products
    • Prehistamine
  • Anticipated Rx-to-OTC Switches
  • New Channels
  • Marketplace Trends
    • Direct-to-Consumer Advertising
    • Building Brands in Prescription Category for Future OTC Switch
    • The Online Healthcare Market
    • Lower Drug Costs Through Outsourcing
  • Flavor Trends
    • Mint Flavor—The New Rage
    • Taste—Major Drawback for Liquids
    • Finally…It is a Medicine
  • Trends in Dosing Forms
    • Convenience—Key for Selecting Kid’s Medicine
    • Tablets Still the Favorite
    • Rapid-Dissolve tablets
    • Oral Strips
    • Cough Sprays
    • Nasal Swabs
    • Spill-Resistant Formulations

Chapter Six: Marketing Dynamics

Advertising Expenditure

  • Television
  • The Leading Ad Spender
  • Ad Spend as a Percentage of Revenues
  • Ad Spend of Non-Sedating Products

 

Positioning

  • Mom’s Brands
  • Comparative Advertisements
  • The Claritin Equivalents

 

Promotional Initiatives

Retail Structure and Distribution

  • Wholesalers
  • Drug Store Chains
  • e-Pharmacies
  • Retail Distribution
  • Drugstores

 

The Role of the Pharmacist

The Most Recommended Brand

Retail Trends

  • Impulse Purchase High for OTC Products
  • Piggybacking on National Brands
  • Supermarkets Stress ‘Whole Health’
  • Dedicated Kids Ailment Center
  • Entry of Dollar Stores
  • FSAs
  • Mail Order and Internet

 

New Product Introductions

  • Selling Points by Package Tags
  • Innovative Products
  • Alternative Products

Chapter Seven: Company Profiles

  • Procter & Gamble
    • Overview
    • Healthcare Segment
    • Performance
    • “Launch & Leverage”
  • Cadbury Schweppes
    • Overview
    • “Halls” of Fame
    • Sustainable growth
    • “Voicevertising”- A Unique Marketing Strategy
  • Johnson & Johnson
    • Overview
    • Makers of Tylenol
    • OTC CCSA Product Line
  • Pfizer
    • Overview
    • OTC CCSA Product Line
    • Performance
    • Largest Pharmaceutical R&D Organization
    • Focus on Pharmaceuticals and Healthcare
  • Wyeth Inc.
    • Overview
    • Product Line
    • Performance
    • Target: Two Novel Medicines Annually
  • Bayer Group
    • Overview
    • U.S. Operations
    • OTC CCSA Product Line
    • Performance
    • Bayer: Expanding Its Reach
  • Bristol-Myers Squibb Company
    • Overview
    • OTC Product Line
    • Renewed Strategy—Focus on Prescription Drugs
  • Novartis
    • Overview
    • The Consumer Health Division
    • OTC Product Line
    • R&D: The Company’s Lifeblood
  • Schering Plough Corporation
    • Overview
    • OTC Product Line
    • Performance
    • Recent News
  • Matrixx Initiatives Inc.
    • Overview
    • OTC Product Line
    • Performance
    • Unique Innovations
  • Leiner
    • Overview
    • Cost: The Driving Factor
    • Social Responsibility

Appendix a: Company Directory

Appendix b: Advertising Tag Lines for Selected Brands

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: U.S. Retail Cough/Cold/Allergy/Sinus Medications Market 2000-2004

Chapter Two: The Market

  • Table 2-1: Common OTC Medications for Cough, Cold, Allergy and Sinus Conditions
  • Table 2-2: Major Antihistamines Brands and Year of OTC Switch
  • Table 2-3: Selected Combination Products
  • Figure 2-1: Performances of OTC Categories, 2000-2004
  • Table 2-4: U.S. Retail Sales of Cough/Cold/Allergy/Sinus Medications, 2000-2004
  • Figure 2-2: Cough/Cold/Allergy/Sinus Medications Sales Trend
  • Figure 2-3: Market Breakups: Share of Top 3 Marketers, Next 5 Marketers, Private Labels, and All Others 2000-2004
  • Figure 2-4: Overall Mass-Market Share by Competitor 2004
  • Table 2-5: Mass-Market Sales for Top 10 Marketers, Private Labels, and
  • Others 2000-2004
  • Figure 2-5: Brand’s Market-share Break-up, 2004
  • Table 2-6: Mass-Market Sales for Top 10 Brands, Private Labels, and
  • Others 2000-2004
  • Figure 2-6: Cough/Cold/Allergy/Sinus Market Composition, 2000-2004
  • Table 2-7: Mass-Market Sales for Cough/Cold/Allergy/Sinus Medications by
  • Type (18 Categories) 2000-2004
  • Figure 2-7: Projected Market for U.S. Cough/Cold/Allergy/Sinus
  • Medication, 2005-2009
  • Table 2-8: Stages in Clinical Trial
  • Figure 2-8: OTC Review Process
  • Table 2-9: Selected OTC Cold/Allergy/Cough Ingredient
  • Approvals 1976-2002
  • Table 2-10: Residential Population Share by Age Group 2000-2015

Chapter Three: The Marketers

  • Figure 3-1: U.S. Cold Allergy Sinus Market Classification 2004
  • Figure 3-2: U.S. Cold Allergy Sinus Mass-Market Sales 2000-2004
  • Table 3-1: Mass-Market Sales of Top Cold Allergy Sinus Brands 2000-2004
  • Table 3-2: Mass-Market Sales of Top Cold Allergy Sinus Marketers 2000-2004
  • Table 3-3: Mass-Market Sales of Top Cold Allergy Sinus Marketers, Brands 2000-2004
  • Figure 3-3: U.S. Non-Sedating Antihistamine Retail Sales 2000-2004
  • Table 3-4: Mass-Market Sales of Top Non-Sedating Antihistamine Brands 2000-2004
  • Table 3-5: Mass-Market Sales of Top Non-Sedating Antihistamine Marketers 2000-2004
  • Figure 3-4: U.S. Decongestant Retail Sales 2000-2004
  • Table 3-6: Mass-Market Sales of Top Decongestant Brands 2000-2004
  • Table 3-7: Mass-Market Sales of Top Decongestant Marketers 2000-2004
  • Figure 3-5: U.S. Cough Medication Mass Market Sales, 2000-2004
  • Table 3-8: Mass-Market Sales of Top Cough Medication Brands 2000-2004
  • Table 3-9: Mass-Market Sales of Top Cough Medication Marketers 2000-2004
  • Table 3-10: Mass-Market Sales of Top Expectorant Cough Medication Marketers, Brands 2000-2004
  • Figure 3-6: U.S. Antitussives Medication Mass-Market Sales 2000-2004
  • Table 3-11: Mass-Market Sales of Top Antitussives Brands 2000-2004
  • Table 3-12: Mass-Market Sales of Top Antitussives Marketers 2000-2004
  • Figure 3-7: U.S. Combination Medication Mass-Market Sales 2000-2004
  • Table 3-13: Mass-Market Sales of Top Combination Brands, 2000-2004
  • Table 3-14: Mass-Market Sales of Top Combination Marketers, 2000-2004
  • Table 3-15: Mass-Market Sales of Combination Drugs Containing Pseudoephedrine vs Other Combinations 2003-2004
  • Table 3-16: Mass Market Sales of Combination Brands Containing Pseudoephedrine 2003-2004
  • Figure 3-8: U.S. Cough Combination Mass-Market Sales 2000 – 2004
  • Table 3-17: Mass-Market Sales of Top Cough Combination Brands 2000-2004
  • Table 3-18: Mass-Market Sales of Top Cough Combination Marketers 2000-2004
  • Figure 3-9: U.S. Cold Sinus Allergy Combination Mass-Market Sales 2000-2004
  • Table 3-19: Mass-Market Sales of Top Cold Sinus Allergy Combination Brands 2000-2004
  • Table 3-20: Mass-Market Sales of Top Cold Sinus Allergy Combination Marketers 2000-2004
  • Figure 3-10: U.S. Others Mass-Market Sales 2000 – 2004
  • Table 3-21: Mass-Market Sales of Top Other Brands 2000-2004
  • Table 3-22: Mass-Market Sales of Top Other Marketers 2000-2004
  • Figure 3-11: U.S. Cough Other Mass-Market Sales 2000-2004
  • Table 3-23: Mass-Market Sales of Top Cough Other Brands 2000-2004
  • Table 3-24: Mass-Market Sales of Top Cough Other Marketers 2000-2004
  • Figure 3-12: U.S. Cold Sinus Allergy Other Mass-Market Sales 2000- 2004
  • Table 3-25: Mass-Market Sales of Top Cold Sinus Allergy Other Brands 2000-2004
  • Table 3-26: Mass-Market Sales of Top Cold Sinus Allergy Other Marketers 2000-2004
  • Figure 3-13: U.S. Nasal Products Mass-Market Sales 2000-2004
  • Table 3-27: Mass Market Sales of Nasal Products by Type (Spary/Drops/Inhalers, Strips, Mast Cell Stabilizers, Aspirators) 2000-2004
  • Table 3-28: Mass-Market Sales of Top Nasal Products Marketers 2000-2004
  • Table 3-29: Mass-Market Sales of Top Nasal Products Brands 2000-2004
  • Figure 3-14: U.S. Nasal Sprays/Inhalers/Drops Mass-Market Sales 2000-2004
  • Table 3-30: Mass-Market Sales of Top Nasal Sprays/Inhalers/Drops Brands 2000-2004
  • Table 3-31: Mass-Market Sales of Top Nasal Sprays/Inhalers/Drops Marketers 2000-2004
  • Figure 3-15: U.S. Nasal Aspirators Mass-Market Sales 2000-2004
  • Table 3-32: Mass-Market Sales of Top Nasal Aspirators Marketers/ Brands 2000-2004
  • Table 3-33: Mass-Market Sales of Top Mast Cell Stabilizers Brands 2000-2004
  • Table 3-34: Mass-Market Sales of Top Nasal Strip Marketers/Brands 2000-2004
  • Figure 3-16: U.S. Chest Rubs Mass-Market Sales 2000-2004
  • Table 3-35: Mass-Market Sales of Top Chest Rubs Brands 2000-2004
  • Table 3-36: Mass-Market Sales of Top Chest Rubs Marketers 2000-2004

Chapter Four: The Consumer

  • Figure 4-1: Percentage of People Using Non-Prescription Medication Last 12
  • Months, January 2004-September 2004
  • Table 4-1: Adult U.S. Ailments Suffered and at Risk January 2004- Sep-04
  • Table 4-2: Demographic Characteristics of U.S. Adults Favoring OTC over Prescription Products for Ailments January 2004-September 2004
  • Table 4-3: Demographic Profile of U.S. Adult Attitudes Prescription vs. OTC Products January 2004-September 2004
  • Table 4-4: Demographic Profile of U.S. Adult Cold Sinus Allergy Product User January 2004-September 2004
  • Figure 4-2: OTC Usage of Product Based on Condition January 2004- Sep-04
  • Table 4-5: Demographic Profile of U.S. Adult Cold Sinus Allergy Product User by Condition January 2004-September 2004
  • Figure 4-3: Frequency of OTC Product Use by Condition
  • Table 4-6: Demographic Profile of U.S. Adult Cold Sinus Allergy Product Heavy Users (13 or More in 12 Months) January 2004-September 2004
  • Table 4-7: Top 10 Brands Cold Sinus Allergy January 2004-September 2004
  • Table 4-8: Demographic Profile of U.S. Adult Cold Sinus Allergy Product Users by Brand, January 2004-September 2004
  • Table 4-9: Demographic Profile of U.S. Adult Sinus & Allergy Product Users by Brand, January 2004-September 2004
  • Table 4-10: Demographic Profile of U.S. Adult Cold Product Users by Brands, January 2004-September 2004
  • Table 4-11: Demographic Profile of U.S. Adult Cold & Sinus Product Users by Brand, January 2004-September 2004
  • Table 4-12: Demographic Profile of U.S. Adult Store Brand Cold Remedy Users, January 2004-September 2004
  • Figure 4-4: Sore Throat Usage Frequency, January 2004-September 2004
  • Figure 4-5: Sore Throat Types Used, January 2004-September 2004
  • Table 4-13: Demographic Profile of U.S. Adult Sore Throat Product User by Type (Drops, Liquids, Lozenges, Sprays) January 2004-September 2004
  • Figure 4-6: Sore Throat Kinds Used, January 2004-September 2004
  • Table 4-14: Demographic Profile of U.S. Adult Sore Throat Product Users by Kinds (Extra-Strength, Regular, Sugar Free, Vitamin C-Based) January 2004-September 2004
  • Table 4-15: Sore Throat—Top 10 Brands, January 2004-September 2004
  • Table 4-16: Demographic Profile of U.S. Adult Sore Throat Product Users by Brands, January 2004-September 2004
  • Table 4-17: Demographic Profile of U.S. Adult Cough Syrup Users January 2004-September 2004
  • Figure 4-7: Users of Cough Syrups by Type (Suppressant vs Expectorant) January 2004-September 2004
  • Table 4-18: Demographic Profile of U.S. Adult Cough Syrup User by Type (Suppressant vs Expectorant) January 2004-September 2004
  • Table 4-19: Demographic Profile of U.S. Adult Cough Syrup Users by Frequency, January 2004-September 2004
  • Table 4-20: Cough Syrups Top 10 Brands January 2004-September 2004
  • Table 4-21: Demographic Profile of U.S. Adult Cough Syrups Users by Brand January 2004-September 2004
  • Table 4-22: Demographic Profile of U.S. Adults Purchasing Children’s Cold/Cough Products, January 2004-September 2004
  • Figure 4-8: Percentage Used for Children’s Cold/Cough Types, January 2004-September 2004
  • Table 4-23: Demographic Profile U.S. Adult Purchasers of Children’s Cold/Cough Products by Types (Chewable, Drops, Liquids, Tablets), January 2004-September 2004
  • Table 4-24: Children’s Cold/Cough Top 10 Brands, January 2004- Sep-04
  • Table 4-25: Demographic Profile of U.S. Adult Purchasers of Children’s Cold/Cough Products by Brand, January 2004-September 2004
  • Table 4-26: Demographic Profile of U.S. Adult Purchasers of Children’s Cold/Cough Products by Brand, January 2004-September 2004

Chapter Five: Issues and Trends

  • Figure 5-1: National Health Expenditure, 1993-2003
  • Table 5-1: Projected U.S. Health Expenditures and Per Capita
  • Income 2005-2010
  • Figure 5-2: Spending for Prescription Drugs by Source of Funds
  • Figure 5-3: Seasonal Variation of the Cough/Cold/Allergy/Sinus Medication Market, 2003-2004
  • Table 5-2: Quarterly Sales by Dosing forms (in $ million), 2003-2004
  • Table 5-3: U.S. Population Under 15 Years of Age 2000-2030
  • Table 5-4: Birth Rate by Women’s Age Group, 2002-2003
  • Table 5-5: Uninsured Population by Age Group, 2003
  • Table 5-6: Combination with Analgesic and OTC Approval
  • Table 5-7: Anticipated Patent Expiry of Major Rx Allergy Drugs, 2003 Sales and DTC Promotional Spend
  • Table 5-8: Number of New Product Introductions by Favor
  • Table 5-9: Cough/Cold/Allergy/Sinus Market by Dosing Form, 2000-2004

Chapter Six: Marketing Dynamics

  • Table 6-1: Preferred Media for Top 20 Brands, 2004
  • Table 6-2: Ad Spend of the Top Five Marketers 2004
  • Table 6-3: Ad Spends as Percentage of Sales by Brand Line 2004
  • Table 6-4: Top Advertisement Spending and Media Channel by Brand 2004
  • Table 6-5: Advertisement Spend and Media Channel of Leading Brands 2004
  • Table 6-6: Tag Line/Positioning Statement of Selected New Product Introductions
  • Table 6-6a: Consumer Promotions of Selected New Product Introductions
  • Figure 6-1: Retail Channel Share of OTC Drug Sales
  • Table 6-7: Distribution of Dollar Volume by Product Type and Channel (Drug Stores, Supermarkets, Other) 2004*
  • Table 6-8: Distribution of Unit Sales by Product Type and Channel (Drug Stores, Supermarkets, Other) 2004*
  • Table 6-9: Customer Reasons for Choosing OTC Medication Brands in 2004
  • Table 6-10: Top Brand Recommended by Pharmacists in Each Category and Percentage of Pharmacists Making Recommendation, 2004
  • Table 6-11: Top Three Pharmacist-Recommended Cough/Cold/Allergy/Sinus Brands by Product Category and Percentage of Pharmacists Making Recommendation, 2004
  • Table 6-12: Top Three Pharmacist-Recommended Nasal Brands by Product Category and Percentage of Pharmacists Making Recommendation, 2004
  • Table 6-13: Top Three Pharmacist-Recommended Children’s Brands by Product Category and Percentage of Pharmacists Making Recommendation, 2004
  • Table 6-14: Top Three Pharmacist-Recommended Sore Throat and Zinc-Based Brand by Product Category and Percentage of Pharmacists Making Recommendation, 2004
  • Table 6-15: Number of New Products Using Selected Selling Points/ Package Tags 2004
  • Table 6-16: Selected Innovative New Product Introductions 2004
  • Table 6-17: Number of New Product Introductions by Major Ingredients 2004
  • Table 6-18: Selected New Product Introductions by Top 10 Marketers 2004
  • Table 6-19: Selected Homeopathic New Product Introductions 2004
  • Table 6-20: Other Selected New Product Introductions 2004
  • Table 6-21: Number of New Product Introductions by Package Type

Chapter Seven: Company Profiles

  • Figure 7-1: P&G OTC CCSA Segmentation
  • Figure 7-2: P&G U.S. Mass-Market OTC CCSA Sales Revenue, 2000-2004
  • Figure 7-3: Mass-Market OTC Sore Throat Drop Sales Comparison: U.S. Vs Cadbury Schweppes, 2000-2004
  • Table 7-1: Johnson & Johnson Product Lines
  • Figure 7-4: Johnson and Johnson OTC CCSA Segmentation
  • Figure 7-5: Johnson & Johnson U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Table 7-2: Pfizer’s Product Lines
  • Figure 7-6: Pfizer OTC CCSA Segmentation
  • Figure 7-7: Pfizer U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-8: Wyeth OTC CCSA Segmentation
  • Figure 7-9: Wyeth U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-10: Bayer OTC CCSA Segmentation
  • Figure 7-11: Bayer U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-12: Bristol Myers Squibb OTC CCSA Segmentation
  • Figure 7-13: Bristol Myers Squibb U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-14: Novartis OTC CCSA Segmentation
  • Figure 7-15: Novartis U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-16: Schering-Plough Corporation OTC CCSA Segmentation
  • Figure 7-17: Schering—Plough Corporation U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004
  • Figure 7-18: Matrixx Initiatives Inc. OTC CCSA Segmentation
  • Figure 7-19: Matrixx Initiatives Inc. U.S. Mass-Market OTC CCSA Sales Revenue 2000-2004

 

    The Market for Rx-to-OTC Switches, 8th Edition
    May 5, 2022
    Global Over-the-Counter (OTC) Drug Markets
    January 23, 2018
    The US Market for Rx to OTC Switches, Forecasts to 2019, 7th Edition
    February 2, 2015
    The U.S. Market for Rx to OTC Switches, 6th Edition
    January 11, 2013

Related products

  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00
  • Placeholder image

    Type II Diabetes: The 45 Market in the United States for Drugs and Diagnostics

    $2,995.00 – $5,990.00
  • Placeholder image

    Market for Generic Biologics: Issues, Trends, and Market Potential, The

    $1,500.00 – $3,000.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and...Wound Care Markets, 2nd Edition, Vol I – Skin Ulcers
Scroll to top